Microbiome Disruption Caused by Antibiotic Overuse in Pediatric Gastroenteritis: A Systematic Review
Abstract
Context: This systematic review examines pediatric gastroenteritis, a prevalent global condition, most commonly of viral origin, with rotavirus, norovirus, and adenovirus as the leading pathogens. Despite this, antibiotics are frequently and inappropriately prescribed, especially in cases without confirmed bacterial etiology, contributing to unnecessary harm. Objectives: This systematic review evaluates the adverse consequences of antibiotic overuse in pediatric gastroenteritis, with emphasis on microbial resistance, gut microbiome disruption, and the risk of severe complications such as Clostridioides difficile infection and hemolytic uremic syndrome (HUS). Data Sources: A systematic search was conducted across PubMed, Embase, Scopus, and Cochrane Library for studies published between 2005 and 2025. Study Selection: Eligible studies included randomized controlled trials, cohort studies, and systematic reviews evaluating antibiotic-related outcomes in children (< 18 years) with clinically or laboratory-confirmed viral gastroenteritis. Data Extraction: The quality of the studies was evaluated using both the Cochrane risk-of-bias tool and the Newcastle-Ottawa Scale. Results: Forty studies met inclusion criteria. Inappropriate antibiotic use in viral gastroenteritis cases was associated with altered gut microbial diversity, increased colonization by opportunistic pathogens, and higher risk of secondary infections. Use of broad-spectrum antibiotics was especially associated with…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.